Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Pain, Postoperative 2 Pain 2 Multiple Myeloma 2 Carcinoma, Non-Small-Cell Lung 2 Agnosia 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Hairy Cell 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma in Situ 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Fulvestrant 63 Letrozole 53 Paclitaxel 49 Trastuzumab 41 pembrolizumab 40 ribociclib 37 Specimen Handling 37 palbociclib 36 Capecitabine 34 Carboplatin 33 Anastrozole 33 Tamoxifen 32 exemestane 29 pertuzumab 28 abemaciclib 28 Magnetic Resonance Spectroscopy 26 Cyclophosphamide 26 trastuzumab deruxtecan 24 Surveys and Questionnaires 21 Radiotherapy 18 Biopsy 18 olaparib 17 Standard of Care 16 Docetaxel 16 Blood Specimen Collection 16 Taxes 14 Mastectomy, Segmental 14 eribulin 13 elacestrant 13 130-nm albumin-bound paclitaxel 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Acetaminophen × 90 days × Clear all

NCT05876390 2026-04-16

IRACPoP

Niguarda Hospital

Enrolling by invitation

Breast Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡